According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...
Early data from the ADAPT JR trial suggest efgartigimod may benefit adolescents with generalized myasthenia gravis, a rare ...
La estrella de los Dodgers de Los Ángeles, Shohei Ohtani, y el toletero de los Yankees de Nueva York, Aaron Judge, están en la contienda para ganar el Premio a ...
The Seahawks are off to their best start since 2020. Jaxon Smith-Njigba could threaten Calvin Johnson for the NFL ...
Duvakitug outperformed placebo at week 14 in endoscopic response and was well tolerated among patients with moderately to severely active Crohn’s disease, according to research presented at ACG Annual ...
Data from the 52-week follow-up of the phase III MINT trial of inebilizumab (Uplizna) in generalized myasthenia gravis was ...
Raymond Penn hopes to develop drugs that manage asthma better and avoid some of the safety and efficacy concerns seen with current therapies.
New study reveals how human astroviruses bind to humans cells and paves the way for new therapies and vaccines ...
Scientists have found that they may be able to use the retina's blood vessels to help predict a person's heart disease risk ...
Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...
CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback